Aortic Stenosis
Understanding Aortic Stenosis (AS), also known as Aortic Valve Stenosis, is crucial for accurate clinical documentation and medical coding. This page provides essential information for healthcare professionals on diagnosing and managing AS, including symptoms, treatment options, and ICD-10 codes related to Aortic Stenosis. Learn about the latest guidelines for Aortic Valve Stenosis diagnosis and improve your healthcare documentation practices.
Narrowing of the aortic valve, obstructing blood flow from the heart.
Chest pain, shortness of breath, dizziness, fainting, heart murmur.
Outpatient cardiology clinic, hospital, cardiac catheterization lab.
ICD-10 Code Families
Complete code families applicable to I35.0
When to use each related code
| Description | When to use |
|---|---|
| Narrowing of the aortic valve opening. | Use for narrowed aortic valve impeding blood flow from left ventricle. Code based on severity (mild, moderate, severe). |
| Aortic valve fails to close completely. | Use for backward blood flow into the left ventricle. Specify acute or chronic, and the cause if known (e.g., rheumatic). |
| Combined stenosis and regurgitation of the aortic valve. | Use when both stenosis and regurgitation of the aortic valve are present. Document severity of both. |
Best-practice checklist
- ✓Document aortic stenosis severity (mild, moderate, severe)
- ✓Aortic valve area assessment required for AS diagnosis
- ✓Symptoms: dyspnea, chest pain, syncope - specify details
- ✓Include echocardiogram findings for aortic stenosis
- ✓AS etiology: congenital, rheumatic, degenerative - document
Common pitfalls to avoid
Coding AS without specifying severity (mild, moderate, severe) can lead to inaccurate DRG assignment and reimbursement.
Failure to distinguish between congenital and acquired AS can impact quality reporting and statistical analysis.
BAV association with AS should be documented and coded for accurate risk stratification and treatment planning.
Best-practice tips
- 01Document AS severity via mean pressure gradient & aortic valve area.
- 02Code accurately using ICD-10 I35.0, I35.2, I35.8, I35.9 as appropriate.
- 03Thorough echo assessment is crucial for AS diagnosis & staging for optimal care.
- 04For asymptomatic severe AS, monitor & document progression with regular echo.
- 05Educate patients on lifestyle modifications & medication adherence for AS management.
Step-by-step checklist
- 1
Confirm systolic murmur radiating to carotids documented.
- 2
Review echocardiogram for aortic valve area and flow velocity.
- 3
Assess for symptoms: dyspnea, syncope, angina documented.
- 4
Check for left ventricular hypertrophy on ECG or imaging.
- 5
Evaluate NYHA functional class and document severity.
Ready-to-paste narrative
Patient presents with symptoms suggestive of aortic stenosis (AS), including exertional dyspnea, chest pain, and syncope. Physical examination revealed a systolic ejection murmur radiating to the carotids, a diminished second heart sound, and a narrow pulse pressure. The patient's medical history includes hypertension and hyperlipidemia. Echocardiography was performed, demonstrating significant left ventricular hypertrophy, reduced aortic valve area, and elevated aortic valve peak velocity consistent with severe aortic stenosis. Differential diagnoses considered included mitral regurgitation, hypertrophic cardiomyopathy, and pulmonary hypertension. The diagnosis of aortic stenosis is confirmed based on the echocardiographic findings and clinical presentation. Treatment plan includes consultation with cardiology for aortic valve replacement (AVR) evaluation. Aortic valve stenosis severity and prognosis were discussed with the patient, including the risks and benefits of AVR versus medical management. Patient education provided on lifestyle modifications, including sodium restriction and medication adherence. ICD-10 code I35.0 (Aortic valve stenosis) and CPT codes for echocardiography (93306, 93308) were used for billing and coding purposes. Follow-up appointment scheduled to reassess symptoms and discuss surgical intervention.
Common questions and answers
What are the key echocardiographic findings suggestive of severe aortic stenosis in asymptomatic patients, and how do these findings influence management decisions?+
In asymptomatic patients, severe aortic stenosis is characterized echocardiographically by an aortic valve area (AVA) of less than 1.0 cm2, a mean aortic valve gradient greater than 40 mmHg, and a peak aortic jet velocity greater than 4.0 m/s. While these criteria are commonly used, it's crucial to also consider other factors like left ventricular ejection fraction (LVEF), the presence of left ventricular hypertrophy, and the patient's overall clinical status. Asymptomatic patients with severe AS and normal LVEF warrant close monitoring with serial echocardiograms, typically every 6-12 months. However, the presence of symptoms, LVEF decline, or other concerning echocardiographic findings may prompt earlier intervention, like aortic valve replacement (AVR). Explore how new guidelines incorporate biomarkers and exercise testing to refine the assessment and management of asymptomatic severe AS patients.
How does low-flow, low-gradient aortic stenosis differ from classic aortic stenosis in terms of diagnosis and management, and what role does dobutamine stress echocardiography play in differentiating these conditions?+
Low-flow, low-gradient aortic stenosis (LFLG AS) presents a diagnostic challenge as it exhibits a reduced AVA and low transvalvular gradient despite severe valvular obstruction. This often occurs in patients with reduced left ventricular ejection fraction (LVEF) which limits the cardiac output and consequently, the transvalvular flow. Differentiating LFLG AS from pseudo-severe AS, where the valve isn't truly severely stenotic, requires careful evaluation. Dobutamine stress echocardiography plays a critical role by increasing cardiac output and revealing the true severity of the stenosis if present. A significant increase in the mean gradient during dobutamine stress suggests true severe AS, whereas a minimal change favors pseudo-severe AS. Consider implementing a multi-parametric approach, including assessment of valve morphology, indexed AVA, and stroke volume index, to accurately diagnose LFLG AS and guide appropriate management strategies.
When considering transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) for aortic stenosis, what are the key patient-specific factors that influence the decision-making process, and how are the latest clinical trial data shaping current practice?+
The decision to pursue TAVR or SAVR for aortic stenosis is highly individualized and based on a comprehensive assessment of patient-specific factors including age, frailty, surgical risk, anatomical suitability for TAVR, and comorbidities. Historically, SAVR was the gold standard, but TAVR has emerged as a preferred option for high-risk surgical patients and is increasingly being considered for intermediate and even low-risk patients based on data from recent clinical trials like PARTNER 3 and Evolut Low Risk. These trials demonstrated non-inferiority and even potential superiority of TAVR over SAVR in certain patient populations regarding outcomes like mortality and stroke. Learn more about the latest evidence and evolving guidelines for TAVR and SAVR selection to ensure optimal patient care.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.